NCT06341842 2024-04-02PROTECTFondazione IRCCS Policlinico San Matteo di PaviaPhase 2 Unknown316 enrolled
NCT05025735 2021-10-19Alpelisib, Fulvestrant and Dapagliflozin for the Treatment of HR+, HER2 -, PIK3CA Mutant Metastatic Breast CancerSaint Luke's Health SystemPhase 2 Unknown25 enrolled